Megan Waldrop, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Sarepta Therapeutics
    Topic:
    DMD/elevidys
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Syneos Health
    Topic:
    vamorolone and dermatomyositis
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
    Relationship end date:
    06/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Sarepta Therapeutics
    Topic:
    improving time to diagnosis in DMD
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    SOLID Biosciences
    Topic:
    DMD gene therapy
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
    Relationship end date:
    11/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Roche Genentech
    Topic:
    SMA fetal risdiplam use
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
    Relationship end date:
    01/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    GemmaBio
    Topic:
    IDMC member for SMA gene therapy product
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Sarepta Therapeutics
    Topic:
    Site PI
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Novartis Gene Therapies
    Topic:
    Site PI
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Scholar Rock
    Topic:
    Site PI
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Biohaven
    Topic:
    Site PI
    Date added:
    07/23/2026
    Date updated:
    07/23/2026
Return to Sleep and Breathing in Pediatric Neuromuscular Disorders (NMD)